Skip to main content
OpenTrials

Clinical trial condition

Lung Diseases, Interstitial

Explore clinical trials studying Lung Diseases, Interstitial. Study availability and eligibility vary by location and protocol.

725 public trials 132 recruiting studies
Refine in advanced search Browse all conditions

Lung Diseases, Interstitial trial results

Completed

A Study to Evaluate the Safety, Preliminary Efficacy, and Pharmacokinetic Properties of LASN01 in Healthy Subjects and in Patients With Pulmonary Fibrosis or Thyroid Eye Disease

NCT05331300

Conditions
Autoimmune Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Endocrine System Diseases, +19 more
Locations
  • Site AU05 Hurstville, New South Wales, Australia
  • Site AU03 Brisbane, Queensland, Australia
  • Site AU01 Melbourne, Victoria, Australia
  • Site HK01 Shatin, Hong Kong
View Trial Details
Completed

Garadacimab Safety, Pharmacokinetics, and Pharmacodynamics in Idiopathic Pulmonary Fibrosis

NCT05130970

Conditions
Idiopathic Pulmonary Fibrosis, Lung Diseases, Lung Diseases, Interstitial, +2 more
Locations
  • The University of Alabama at Birmingham Birmingham, Alabama, United States
  • Pulmonary Associates Clinical Trials AZ Phoenix, Arizona, United States
  • National Institute of Clinical Research Huntington Beach, California, United States
  • University of Southern California - Center for Advanced Lung Disease Los Angeles, California, United States
View all 47 locations
View Trial Details
Completed

Olaparib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With Defects in DNA Damage Repair Genes (A Pediatric MATCH Treatment Trial)

NCT03233204

Conditions
Advanced Malignant Solid Neoplasm, Ann Arbor Stage III Childhood Non-Hodgkin Lymphoma, Ann Arbor Stage IV Childhood Non-Hodgkin Lymphoma, +85 more
Locations
  • Children's Hospital of Alabama Birmingham, Alabama, United States
  • Providence Alaska Medical Center Anchorage, Alaska, United States
  • Banner Children's at Desert Mesa, Arizona, United States
  • Banner University Medical Center - Tucson Tucson, Arizona, United States
View all 113 locations
View Trial Details
Completed

A Study Evaluating the Safety and Efficacy of ENV-101 in Subjects With Idiopathic Pulmonary Fibrosis (IPF)

NCT04968574

Conditions
Fibrosis, Idiopathic Pulmonary Fibrosis, Lung Diseases, +5 more
Locations
  • Research Site Liverpool, New South Wales, Australia
  • Research Site Benowa, Queensland, Australia
  • Research Site Box Hill, Victoria, Australia
  • Research Site Clayton, Victoria, Australia
View all 24 locations
View Trial Details

Related conditions